Today: 21 May 2026
Pentagon awards Lockheed $328.5 million Taiwan IRST pod contract as China drills keep island on alert
2 January 2026
2 mins read

Pentagon awards Lockheed $328.5 million Taiwan IRST pod contract as China drills keep island on alert

WASHINGTON, January 2, 2026, 13:48 ET

  • Taiwan News said the Pentagon set the Lockheed Martin Taiwan Air Force contract at NT$10.3 billion ($328.5 million) and allocated about NT$4.9 billion upfront.
  • Benzinga said the latest Pentagon contracting round also included a $2.73 billion Boeing award tied to Apache helicopter support work.

The Pentagon awarded Lockheed Martin a ceiling $328.5 million undefinitized letter contract — a preliminary deal that lets work begin before final terms are set — for fixed-wing sensor hardware for Taiwan, a U.S. government contracts notice said. The award covers 55 Infrared Search and Track (IRST) Legion Enhanced Sensor pods, which can detect aircraft by heat, plus related equipment under the Foreign Military Sales (FMS) program, the U.S. government’s channel for selling weapons to partners. The notice said $157.3 million in FMS funds were obligated at award, work will be performed in Orlando, Florida, and the project is expected to run through June 30, 2031; it described the deal as a sole-source acquisition.

Taiwan remained on high alert after China staged “Justice Mission 2025” drills around the island, keeping its emergency response centres running as it monitored Chinese naval manoeuvres, Taiwan’s coast guard said. Taiwan’s defence ministry said 77 Chinese military aircraft and 25 navy and coast guard vessels had been operating around the island in the past 24 hours. Lyle Goldstein, Asia programme head at the U.S. think tank Defense Priorities, said: “They threaten and bluster a lot, but ultimately (a war) would be very costly for China no matter what.” Reuters

U.S. arms sales to Taiwan are a persistent source of friction with China, which claims the democratically governed island as its territory and has not ruled out using force. Washington has formal diplomatic ties with Beijing but maintains unofficial relations with Taipei and is bound by law to provide Taiwan with the means to defend itself. In mid-December, the Trump administration announced $11.1 billion in arms sales to Taiwan, described as the largest U.S. weapons package for the island.

FMS deals are structured so the U.S. government manages the sale while contractors build the equipment, often over multiple years.

IRST systems are typically housed in an external pod carried by an aircraft. They help crews track targets by heat rather than radar, which can reduce the aircraft’s electronic signature.

The Pentagon’s use of a letter contract in this case signals urgency, allowing work to begin while final pricing and terms are completed.

Only a portion of the total ceiling value was funded immediately, reflecting how long-duration defence programmes are often financed in stages.

Boeing, another major U.S. defence contractor, also received a $2.7 billion Pentagon award for post-production support services related to Apache helicopters, a separate Reuters report said. The announcement followed a separate $4.7 billion Army contract awarded to Boeing a month earlier for new-build Apache AH-64E attack helicopters, crew trainers and related accessories.

Lockheed and Boeing are part of a small group of “prime” contractors that dominate large Pentagon programmes, from aircraft and missiles to sensors and sustainment work.

The Taiwan-linked award is likely to be closely watched in Beijing and in regional capitals as military activity across the Taiwan Strait keeps intensifying.

The Lockheed contract adds years of work tied to sensors for Taiwan’s air force, at a moment when Taipei is tracking frequent Chinese operations in waters and skies around the island.

Stock Market Today

  • Scotiabank Shares Showing 32% Undervaluation at C$108 Amid Strong Returns
    May 20, 2026, 10:05 PM EDT. Scotiabank (TSX:BNS) stock has rallied to around C$108.50, delivering a 59.4% return over the past year and nearly 79% over five years highlighting strong performance. Despite this, valuation models suggest substantial remaining upside. Simply Wall St's Excess Returns analysis estimates the bank's intrinsic value at approximately C$160 per share, indicating it is 32.2% undervalued compared to current prices. This model calculates excess returns by comparing the bank's return on equity to its cost of equity, reflecting efficient shareholder profit generation. Investors are closely watching key fundamentals including balance sheet resilience and dividend yield as Scotiabank navigates evolving interest rate environments. The stock's valuation score of 4 out of 6 suggests moderate confidence among analysts that price gains can continue.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Boeing (BA) stock jumps today as $2.7 billion Apache support deal kicks off 2026 trading
Previous Story

Boeing (BA) stock jumps today as $2.7 billion Apache support deal kicks off 2026 trading

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal
Next Story

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal

Go toTop